• 11079 Citations
  • 45 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jong-Seok Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 33 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
docetaxel Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR-Mutated Non–Small Cell Lung Cancer

Calvo, E., Lee, J-S., Kim, S. W., Moreno, V., deCastro Carpeno, J., Weilert, D., Laus, G., Mann, H. & Vishwanathan, K., 1 Aug 2019, In : Journal of Clinical Pharmacology. 59, 8, p. 1099-1109 11 p.

Research output: Contribution to journalArticleResearchpeer-review

fexofenadine
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Pharmacokinetics
Protein-Tyrosine Kinases
Stomach Neoplasms
Clinical Trials
Survival
Propensity Score
Drug Therapy
4 Citations (Scopus)

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

Chih-Hsin Yang, J., Shepherd, F. A., Kim, D-W., Lee, G. W., Lee, J-S., Chang, G. C., Lee, S. S., Wei, Y. F., Lee, Y. G., Laus, G., Collins, B., Pisetzky, F. & Horn, L., 1 May 2019, In : Journal of Thoracic Oncology. 14, 5, p. 933-939 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Protein-Tyrosine Kinases
Therapeutics
CD274 Antigen
osimertinib
Safety
8 Citations (Scopus)

Postprogression outcomes for osimertinib versu standard-of-care EGFR-TKI in patients with previously untreated EGFR-mutated advanced non–small cell lung cancer

Planchard, D., Boyer, M. J., Lee, J-S., Dechaphunkul, A., Cheema, P. K., Takahashi, T., Gray, J. E., Tiseo, M., Ramalingam, S. S., Todd, A., McKeown, A., Rukazenkov, Y. & Ohe, Y., 1 Apr 2019, In : Clinical Cancer Research. 25, 7, p. 2058-2063 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Standard of Care
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Confidence Intervals
1 Citation (Scopus)

Prognostic Value of Platelet Count in Patients with Peripheral T Cell Lymphoma

Choi, M., Lee, J. O., Jung, J., Lee, J. Y., Lee, E., Lee, H., Bang, S. M., Eom, H. S. & Lee, J-S., 1 Apr 2019, In : Acta Haematologica. 141, 3, p. 176-186 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Peripheral T-Cell Lymphoma
Platelet Count
Survival
Thrombocytopenia
Disease-Free Survival